 |
05-May-08: Insilicos Awarded Grant for Life Science Computing 03-Apr-08: Insilicos Wins NIH Grant for Manufacturing 14-Jan-08: Insilicos Heart Disease Project Wins Research Funding 30-Aug-07: Insilicos Awarded $1 Million Grant for Biotech Services 30-Apr-07: Insilicos Names Heinecke to Chief Medical Advisor Post 22-Sep-06: Insilicos and GeneBio Sign Global Distribution Agreement 29-May-06: Insilicos Announces Breakthrough Proteomics Software Platform 28-Mar-06: Insilicos Announces 1000th Licensed User of InsilicosViewer 13-Mar-06: Insilicos Awarded Grant to Study Heart Disease 14-Feb-06: Insilicos CEO Erik Nilsson Interviewed 06-Feb-06: Insilicos Awarded Grant to Commercialize Proteomics Research 14-Sep-05: Insilicos announces support for biotech data format 31-Aug-05: Insilicos Announces Web Support for Biotech Tools 08-Jul-05: Insilicos appoints Teresa Skarr as Director of Regulatory Affairs 04-Jun-05: Insilicos Announces 500th Licensed User of InsilicosViewer 27-Apr-05: Insilicos Presents at Invest Northwest 31-Mar-05: Insilicos releases new version of viewer 23-Feb-05: Insilicos Awarded Proteomics Grant 14-Dec-04: Ruedi Aebersold joins Insilicos Advisory Board 01-Sep-04: InsilicosViewer in the News 15-Apr-04: Insilicos Wins NIH Grant 13-Oct-03: Insilicos Releases Beta 26-Jun-03: Insilicos Wins Grant 30-Sep-02: Insilicos Platform Project Announced
| |
|
Insilicos Names Heinecke to Chief Medical Advisor Post
|
|
30 April 2007, Seattle, WA, USA:
Biomedical software firm Insilicos today announced that Jay Heinecke, M.D. has joined Insilicos' Scientific Advisory Board with the title of Chief Medical Advisor.
Dr. Heinecke is a Professor in the University of Washington Department of Medicine and a member of the Molecular Cell Biology program of the School of Medicine. He holds the Karasinski Chair in Metabolic Research and serves as Director of the Mass Spectrometry Resource for the UW Department of Medicine. Research in the Heinecke laboratory focuses on the role of oxidative reactions in the pathogenesis of atherosclerosis and other inflammatory diseases.
"Dr. Heinecke is both a practicing medical doctor and a pioneer in diagnostic proteomics," said Insilicos Chief Scientist Dr. Bryan Prazen. "Heinecke's advice and insight will be of critical importance as Insilicos moves closer to the clinic."
"Dr. Heinecke's expertise supports Insilicos' ambition to revolutionize the diagnosis of cardiovascular disease," said Insilicos President Erik Nilsson. "Insilicos' outstanding advisory board shows our connection to cutting-edge research. Heinecke's appointment reflects our growing strength in clinical applications."
Insilicos' Scientific Advisory Board comprises:
Ruedi Aebersold, Professor of Systems Biology, Institute of Biotechnology, Swiss Federal Institute of Technology, Zürich.
Norman Dovichi, Endowed Professor of Analytical Chemistry, University of Washington.
David Robinson Goodlett, Associate Professor, Department of Medicinal Chemistry, University of Washington.
Jay Heinecke, Endowed Professor of Medicine, University of Washington Medical School.
Nels Olson, Chief of Preservation Research and Testing, Library of Congress.
More information on Insilicos' Advisory Board can be found at www.insilicos.com/about.htmlInsilicos LLC develops life science software for pharmaceutical development, biological research and clinical diagnostics.
For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' and 'Life Science Software' are trademarks of Insilicos LLC.
|
|
